mariPOC® will soon launch a test to detect COVID-19 infection caused by novel coronavirus (SARS-CoV-2)

Read more

The complete solution for decentralized infection diagnostics

Read more

mariPOC® test for C. difficile reports GDH and toxins simultaneously!

Read more

Quick StrepA results in 15 minutes - sensitivity equal to bacterial culture

Read more

Ensure correct pathogen-specific diagnosis and treatment with broad test panels!

Read more

mariPOC® test system

mariPOC® test system enables fast and accurate diagnosis in acute infections. Multiple pathogens are tested from a single clinical sample simultaneously. The fully automated test system enables central laboratory sensitivity and specificity in rapid and decentralized testing. The quality of the results is ensured by a unique internal autoverification system. These together with ease of use make mariPOC® perfectly suitable also for point-of-care testing (POCT).



Press Release: ArcDia’s products would allow testing of all respiratory tract and COVID-19 patients in Finland

Turku Finland, March 26, 2020 – the Finnish medical device manufacturer ArcDia International Ltd reports...


Press Release: ArcDia International Ltd develops a COVID-19 test for primary care

Turku Finland, March 11, 2020 – the Finnish medical device manufacturer ArcDia International Ltd develops...


Pathogen Detection in Perianal Streptococcal Dermatitis

ArcDia International Ltd is pleased to announce that perianal streptococcal dermatitis has been added as...


13.4. - 16.4.2019

ECCMID 2019, Amsterdam, Netherlands

You are invited to visit booth 1.7f and meet mariPOC® team! At our booth you...

21.4. - 24.4.2018

ECCMID 2018, Madrid, Spain

Welcome to experience our exciting mariPOC® booth #100 in ECCMID 2018, Madrid, Spain, April 21st...

8.3. - 9.3.2018

Finnish Virology days

mariPOC is present in Finnish Virology days in Tuusula, Finland. Welcome to have a chat...